235 related articles for article (PubMed ID: 1358388)
1. Imidazoline antagonists of alpha 2-adrenoceptors increase insulin release in vitro by inhibiting ATP-sensitive K+ channels in pancreatic beta-cells.
Jonas JC; Plant TD; Henquin JC
Br J Pharmacol; 1992 Sep; 107(1):8-14. PubMed ID: 1358388
[TBL] [Abstract][Full Text] [Related]
2. In vitro stimulation of insulin release by SL 84.0418, a new alpha 2-adrenoceptor antagonist.
Jonas JC; Plant TD; Angel I; Langer SZ; Henquin JC
Eur J Pharmacol; 1994 Mar; 254(1-2):27-33. PubMed ID: 7911430
[TBL] [Abstract][Full Text] [Related]
3. The imidazoline SL 84.0418 shows stereoselectivity in blocking alpha 2-adrenoceptors but not ATP-sensitive K+ channels in pancreatic B-cells.
Jonas JC; Garcia-Barrado MJ; Angel I; Henquin JC
Eur J Pharmacol; 1994 Oct; 264(1):81-4. PubMed ID: 7828647
[TBL] [Abstract][Full Text] [Related]
4. Phentolamine and yohimbine inhibit ATP-sensitive K+ channels in mouse pancreatic beta-cells.
Plant TD; Henquin JC
Br J Pharmacol; 1990 Sep; 101(1):115-20. PubMed ID: 2282453
[TBL] [Abstract][Full Text] [Related]
5. Clonidine inhibits ATP-sensitive K+ channels in mouse pancreatic beta-cells.
Plant TD; Jonas JC; Henquin JC
Br J Pharmacol; 1991 Oct; 104(2):385-90. PubMed ID: 1686736
[TBL] [Abstract][Full Text] [Related]
6. ATP-sensitive potassium channels and efaroxan-induced insulin release in the electrofusion-derived BRIN-BD11 beta-cell line.
Chapman JC; McClenaghan NH; Cosgrove KE; Hashmi MN; Shepherd RM; Giesberts AN; White SJ; Ammälä C; Flatt PR; Dunne MJ
Diabetes; 1999 Dec; 48(12):2349-57. PubMed ID: 10580423
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneous characteristics of imidazoline-induced insulin secretion.
Rustenbeck I; Leupolt L; Kowalewski R; Hasselblatt A
Naunyn Schmiedebergs Arch Pharmacol; 1999 Mar; 359(3):235-42. PubMed ID: 10208311
[TBL] [Abstract][Full Text] [Related]
8. Effects of putative activators of K+ channels in mouse pancreatic beta-cells.
Garrino MG; Plant TD; Henquin JC
Br J Pharmacol; 1989 Nov; 98(3):957-65. PubMed ID: 2531623
[TBL] [Abstract][Full Text] [Related]
9. An insulin-releasing property of imidazoline derivatives is not limited to compounds that block alpha-adrenoceptors.
Schulz A; Hasselblatt A
Naunyn Schmiedebergs Arch Pharmacol; 1989 Sep; 340(3):321-7. PubMed ID: 2572976
[TBL] [Abstract][Full Text] [Related]
10. Block of ATP-regulated potassium channels by phentolamine and other alpha-adrenoceptor antagonists.
Dunne MJ
Br J Pharmacol; 1991 Aug; 103(4):1847-50. PubMed ID: 1680516
[TBL] [Abstract][Full Text] [Related]
11. Imidazoline/guanidinium binding sites and their relation to inhibition of K(ATP) channels in pancreatic B-cells.
Rustenbeck I; Herrmann C; Ratzka P; Hasselblatt A
Naunyn Schmiedebergs Arch Pharmacol; 1997 Sep; 356(3):410-7. PubMed ID: 9303581
[TBL] [Abstract][Full Text] [Related]
12. Effects of imidazoline compounds on cytoplasmic Ca2+ concentration and ATP-sensitive K+ channels in pancreatic B-cells.
Rustenbeck I; Kowalewski R; Herrmann C; Dickel C; Ratzka P; Hasselblatt A
Exp Clin Endocrinol Diabetes; 1995; 103 Suppl 2():42-5. PubMed ID: 8839253
[TBL] [Abstract][Full Text] [Related]
13. BPDZ 154 activates adenosine 5'-triphosphate-sensitive potassium channels: in vitro studies using rodent insulin-secreting cells and islets isolated from patients with hyperinsulinism.
Cosgrove KE; Antoine MH; Lee AT; Barnes PD; de Tullio P; Clayton P; McCloy R; De Lonlay P; Nihoul-Fékété C; Robert JJ; Saudubray JM; Rahier J; Lindley KJ; Hussain K; Aynsley-Green A; Pirotte B; Lebrun P; Dunne MJ
J Clin Endocrinol Metab; 2002 Nov; 87(11):4860-8. PubMed ID: 12414839
[TBL] [Abstract][Full Text] [Related]
14. The alpha 2-adrenoceptor antagonist efaroxan modulates K+ATP channels in insulin-secreting cells.
Chan SL; Dunne MJ; Stillings MR; Morgan NG
Eur J Pharmacol; 1991 Oct; 204(1):41-8. PubMed ID: 1687123
[TBL] [Abstract][Full Text] [Related]
15. The effect of some alpha-adrenoceptor antagonists on spontaneous myogenic activity in the rat portal vein and the putative involvement of ATP-sensitive K+ channels.
Schwietert R; Wilhelm D; Wilffert B; Van Zwieten PA
Eur J Pharmacol; 1992 Jan; 211(1):87-95. PubMed ID: 1352250
[TBL] [Abstract][Full Text] [Related]
16. Antagonism of levcromakalim by imidazoline- and guanidine-derivatives in rat portal vein: involvement of the delayed rectifier.
Ibbotson T; Edwards G; Weston AH
Br J Pharmacol; 1993 Dec; 110(4):1556-64. PubMed ID: 8306101
[TBL] [Abstract][Full Text] [Related]
17. Desensitization of insulin secretory response to imidazolines, tolbutamide, and quinine. II. Electrophysiological and fluorimetric studies.
Rustenbeck I; Dickel C; Grimmsmanns T
Biochem Pharmacol; 2001 Dec; 62(12):1695-703. PubMed ID: 11755123
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological stimulation and inhibition of insulin secretion in mouse islets lacking ATP-sensitive K+ channels.
Szollosi A; Nenquin M; Henquin JC
Br J Pharmacol; 2010 Feb; 159(3):669-77. PubMed ID: 20128805
[TBL] [Abstract][Full Text] [Related]
19. Multiple effects and stimulation of insulin secretion by the tyrosine kinase inhibitor genistein in normal mouse islets.
Jonas JC; Plant TD; Gilon P; Detimary P; Nenquin M; Henquin JC
Br J Pharmacol; 1995 Feb; 114(4):872-80. PubMed ID: 7773549
[TBL] [Abstract][Full Text] [Related]
20. Imidazolines stimulate release of insulin from RIN-5AH cells independently from imidazoline I1 and I2 receptors.
Olmos G; Kulkarni RN; Haque M; MacDermot J
Eur J Pharmacol; 1994 Sep; 262(1-2):41-8. PubMed ID: 7813577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
